Target Price | $29.95 |
Price | $22.24 |
Potential |
34.69%
register free of charge
|
Number of Estimates | 22 |
22 Analysts have issued a price target Privia Health Group 2026 .
The average Privia Health Group target price is $29.95.
This is
34.69%
register free of charge
$40.00
79.86%
register free of charge
$21.00
5.58%
register free of charge
|
|
A rating was issued by 23 analysts: 21 Analysts recommend Privia Health Group to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2026 of
34.69%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 1.74 | 1.87 |
4.74% | 7.50% | |
EBITDA Margin | 1.40% | 5.75% |
14.82% | 311.72% | |
Net Margin | 0.76% | 1.54% |
44.73% | 102.06% |
21 Analysts have issued a sales forecast Privia Health Group 2025 . The average Privia Health Group sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Privia Health Group EBITDA forecast 2025. The average Privia Health Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Privia Health Group Analysts have issued a net profit forecast 2025. The average Privia Health Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.11 | 0.24 |
42.11% | 118.18% | |
P/E | 93.11 | |
EV/Sales | 1.20 |
14 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group EPS is
This results in the following potential growth metrics and future valuations:
Privia Health Group...
Analyst | Rating | Action | Date |
---|---|---|---|
Needham |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Needham |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
Needham |
Locked
➜
Locked
|
Locked | Jan 15 2025 |
Analyst Rating | Date |
---|---|
Locked
Needham:
Locked
➜
Locked
|
Mar 21 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Needham:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Feb 14 2025 |
Locked
Needham:
Locked
➜
Locked
|
Jan 15 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.